• Prurigo diagnosis
    Medical News

    Prurigo Nodularis Diagnosis Centers on Clinical Recognition, Not Biopsy, Dr. Elmariah Says

  • Doctor
    Medical News

    Prurigo Nodularis Linked to Elevated Cardiovascular Risk, Expanding View of Systemic Disease

  • Alopecia
    Medical News

    GLP-1 Receptor Agonists Show Complex, Evolving Role in Alopecia Areata

advertisement
advertisement

Programs

  • Double-Class Refractory CLL in Community Practice: Current and Future Management
    CME/CE

    Double-Class Refractory CLL in Community Practice: Current and Future Management

    0.25 credits
  • Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Canc…
    AudioAbstracts

    Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer

  • Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
    CME/CE

    Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026

    0.25 credits
  • From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibo…
    CME/CE

    From Late-Line Rescue to Early-Line Option: The Potential for Bispecific Antibodies in Multiple Myeloma

    0.25 credits
  • Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
    CME/CE

    Navigating Treatment Sequencing After Frontline Treatment Failure in CLL

    0.25 credits
  • Strategies to Safeguard Brain Health in MS
    NeuroFrontiers

    Strategies to Safeguard Brain Health in MS

advertisement

Clinical Practice

  • The Burden of Cognitive Dysfunction in Multiple Sclerosis
    NeuroFrontiers

    The Burden of Cognitive Dysfunction in Multiple Sclerosis

  • Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
    MinuteCE®

    Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice

    0.75 program credits
  • Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum
    CME/CE

    Advancing Care in HNSCC: Evolving Strategies Across the Disease Continuum

    0.50 credits
  • GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
    CME/CE

    GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?

    0.25 credits
  • Living with Psoriatic Arthritis: A Doctor-Patient Conversation
    Medical Industry Feature

    Living with Psoriatic Arthritis: A Doctor-Patient Conversation

  • The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite…
    MinuteCE®

    The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT

    0.75 credits 5 episodes
advertisement

Doctors Lounge

  • The Convergence

    "We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician

  • “We see 40 million Americans a day using ChatGPT for health and wellness-relate…
    The Convergence

    “We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI

  • The Convergence

    "A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm

  • Death by Planet? Strange Diagnoses from 1632 London’s Medical Records
    Rub Some Dirt In It

    Death by Planet? Strange Diagnoses from 1632 London’s Medical Records

  • Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
    Project Oncology®

    Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI

  • Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
    Clinician's Roundtable

    Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies

advertisement

CME

  • Personalizing First-Line Therapy for CLL
    CME/CE

    Personalizing First-Line Therapy for CLL

    0.25 credits
  • When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
    MinuteCE®

    When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF

    0.75 program credits
  • Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative…
    CME/CE

    Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

    0.25 credits
  • Applying Advances in Practice:  Case-Based Look at Selecting Therapy for Cushin…
    CME/CE

    Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome

    0.25 credits
  • GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layeri…
    MinuteCE®

    GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF

    0.75 program credits
  • NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
    MinuteCE®

    NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors

    0.75 program credits
advertisement

Industry Feature

  • Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
    Medical Industry Feature

    Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture

  • Gene Therapy, the Future of Eye Care?
    Medical Industry Feature

    Gene Therapy, the Future of Eye Care?

  • Research Uncovers a Potential Biomarker for Postpartum Depression Risk
    Medical Industry Feature

    Research Uncovers a Potential Biomarker for Postpartum Depression Risk

  • Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
    Medical Industry Feature

    Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

  • Bridging the Gap in AYA Cure Rates
    Medical Industry Feature

    Bridging the Gap in AYA Cure Rates

  • Groundbreaking AI Models Transform Cardiovascular Diagnosis
    Medical Industry Feature

    Groundbreaking AI Models Transform Cardiovascular Diagnosis

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free